As Promised, Rosetta Expands Dx Pipeline With Trio of Cancer, Women’s Health Tests

Rosetta Genomics said that the new diagnostics will be available between 2009 and 2010, and will be developed and commercialized through its soon-to-be acquired CLIA laboratory.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories